Related Experiment Video
Updated: Feb 17, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Docosahexaenoic acid and the preterm infant
Stephanie L Smith1, Christopher A Rouse1,2
1Uniformed Services University of Health Sciences, 4301 Jones Bridge, Bethesda, MD 20814 USA.
Insights
Docosahexaenoic acid (DHA) is crucial for infant development. Studies show mixed results on optimal DHA supplementation for premature infants, highlighting the need for further research.
Area of Science:
- Neonatal nutrition
- Neuroscience
- Immunology
Background:
- Docosahexaenoic acid (DHA), a vital long-chain poly-unsaturated fatty acid (LCPUFA), supports cognitive, visual, and immune development in newborns.
- Premature infants often lack sufficient DHA due to interrupted third-trimester accretion and reliance on variable breast milk levels.
- Maternal diet significantly impacts breast milk DHA content, with Western diets often leading to lower levels.
Purpose of the Study:
- To review the current understanding of DHA's role in infant development.
- To explore the challenges and inconsistencies in DHA supplementation for premature infants.
- To identify the need for optimized DHA intake strategies in preterm neonates.
Main Methods:
- Literature review of studies on DHA supplementation in premature infants.
- Analysis of factors influencing DHA levels in breast milk.
- Evaluation of existing research on cognitive and immunological outcomes.
Main Results:
- DHA is essential for neonatal development, particularly in premature infants.
- Breast milk DHA content is directly related to maternal intake.
- Supplementation trials show inconsistent results regarding optimal dosage and delivery methods for preterm infants.
Conclusions:
- While short-term benefits of DHA supplementation are observed, long-term outcomes remain inconsistent.
- Further research is necessary to establish optimal DHA supplementation protocols for premature infants.
- Optimizing DHA intake is critical for improving cognitive and immunological outcomes in this vulnerable population.
Abstract:
Docosahexaenoic acid (DHA) is a long chain poly-unsaturated fatty acid (LCPUFA) that has a role in the cognitive and visual development, as well as in the immune function of newborns. Premature infants are typically deficient in DHA for several reasons, to include fetal accretion of DHA that typically occurs during the third trimester. These premature infants are reliant on enteral sources of DHA, most commonly through breast milk. The DHA content in breast milk varies in direct correlation with maternal DHA intake and mothers consuming a Western diet typically have lower levels of DHA in their breast milk. Maternal DHA supplementation and direct supplementation of DHA to the infant has been tried successfully but there are still conflicting results on the optimal dosage and method of delivery of DHA to the infant. This has led to inconsistent results in trials evaluating the effects of DHA supplementation to the preterm infant in terms of cognitive and immunological outcomes. While short-term benefits have been seen in several studies, long-term benefits are not consistent. Future studies continue to be needed to optimize DHA intake in our premature infants.
More Related Videos
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
01:07Teratogenicity
01:29Drug Dosing: Infants and Children
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution